Remix Therapeutics

Skyhawk Therapeutics

This company develops small molecules that modulate RNA for patients with rare neurological, oncological, and autoimmune diseases.

Ribometrix

The company develops small molecule therapeutics targeting RNA structures to treat human diseases for pharmaceutical partners and patients with cancer or neurodegenerative conditions.

Relay Therapeutics

This company develops small molecule medicines for patients with cancer and genetic diseases by using a platform that models protein motion.

Arrakis Therapeutics

This biopharmaceutical company develops oral, small-molecule medicines that target RNA to treat patients with cancer, cardiovascular conditions, neurodegeneration and rare genetic diseases.

Pretzel Therapeutics

This biotechnology company develops small-molecule therapies for patients with mitochondrial dysfunction, including rare genetic conditions and common neurodegenerative diseases.

Ribon Therapeutics

This biotechnology company develops small molecule inhibitors targeting stress support pathways for patients with cancer and inflammatory diseases.

Kymera Therapeutics

This biotechnology company develops small molecule medicines that degrade disease-causing proteins for patients with cancer and immune-inflammatory diseases.

Redona Therapeutics

This biotechnology company develops small molecule therapies targeting nucleic acid regulators to treat cancer and autoimmune diseases for healthcare providers and pharmaceutical partners.